• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过杂交 SELEX 技术筛选靶向 B7H3 的 DNA 适体:免疫测定的抗体替代物。

Development of DNA aptamers targeting B7H3 by hybrid-SELEX: an alternative to antibodies for immuno-assays.

机构信息

L&T Ocular Pathology Department, Vision Research Foundation, Sankara Nethralaya, No. 41, College Road, Nungambakkam, Chennai, Tamil Nadu, 600006, India.

School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India.

出版信息

Sci Rep. 2024 Jun 12;14(1):13552. doi: 10.1038/s41598-024-64559-7.

DOI:10.1038/s41598-024-64559-7
PMID:38866941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11169341/
Abstract

Antibodies have been extensively used in numerous applications within proteomics-based technologies, requiring high sensitivity, specificity, a broad dynamic range for detection, and precise, reproducible quantification. Seeking alternatives to antibodies due to several inherent limitations of antibodies is an area of active research of tremendous importance. Recently, aptamers have been receiving increasing attention, because they not only have all of the advantages of antibodies, but also have unique advantages, such as thermal stability, low cost, and unlimited applications. Aptamers are gaining importance in immunological studies and can potentially replace antibodies in immunoassays. B7H3, an immunoregulatory protein belonging to the B7 family, is an attractive and promising target due to its overexpression in several tumor tissues while exhibiting limited expression in normal tissues. This study employed hybrid-SELEX with next-generation sequencing to select ssDNA aptamers specifically binding to the B7H3 protein. These aptamers demonstrated versatility across various assays, including flow cytometry, dot-blot, and immunohistochemistry. Effective performance in sandwich dot-blot assays and western blot analysis suggests their potential for diagnostic applications and demonstrates their adaptability and cost-effectiveness in diverse protein detection techniques.

摘要

抗体在基于蛋白质组学的技术的众多应用中被广泛使用,需要高灵敏度、特异性、宽动态检测范围以及精确、可重复的定量。由于抗体存在一些固有局限性,因此寻找替代抗体的方法是一个非常重要的研究领域。最近,适体越来越受到关注,因为它们不仅具有抗体的所有优势,而且具有独特的优势,如热稳定性、低成本和无限的应用。适体在免疫学研究中越来越重要,并且有可能在免疫测定中替代抗体。B7H3 是一种免疫调节蛋白,属于 B7 家族,由于其在几种肿瘤组织中过度表达,而在正常组织中表达有限,因此是一个有吸引力和有前途的靶标。本研究采用杂交-SELEX 与下一代测序相结合的方法,筛选出特异性结合 B7H3 蛋白的 ssDNA 适体。这些适体在包括流式细胞术、斑点印迹和免疫组织化学在内的各种检测中表现出多功能性。在夹心斑点印迹和 Western blot 分析中的有效性能表明它们具有用于诊断应用的潜力,并证明了它们在各种蛋白质检测技术中的适应性和成本效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/f040d299c248/41598_2024_64559_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/4484d87637fb/41598_2024_64559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/acf20e205c33/41598_2024_64559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/82b197fa6d02/41598_2024_64559_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/8b007710b51b/41598_2024_64559_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/f040d299c248/41598_2024_64559_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/4484d87637fb/41598_2024_64559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/acf20e205c33/41598_2024_64559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/82b197fa6d02/41598_2024_64559_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/8b007710b51b/41598_2024_64559_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/11169341/f040d299c248/41598_2024_64559_Fig5_HTML.jpg

相似文献

1
Development of DNA aptamers targeting B7H3 by hybrid-SELEX: an alternative to antibodies for immuno-assays.通过杂交 SELEX 技术筛选靶向 B7H3 的 DNA 适体:免疫测定的抗体替代物。
Sci Rep. 2024 Jun 12;14(1):13552. doi: 10.1038/s41598-024-64559-7.
2
Replacing antibodies with aptamers in lateral flow immunoassay.用适体替代侧向流免疫分析中的抗体。
Biosens Bioelectron. 2015 Sep 15;71:230-242. doi: 10.1016/j.bios.2015.04.041. Epub 2015 Apr 14.
3
Aptamers and the next generation of diagnostic reagents.适配体与下一代诊断试剂。
Proteomics Clin Appl. 2012 Dec;6(11-12):563-73. doi: 10.1002/prca.201200042.
4
SELEX methods on the road to protein targeting with nucleic acid aptamers.SELEX 方法在利用核酸适体进行蛋白质靶向中的应用。
Biochimie. 2018 Nov;154:132-155. doi: 10.1016/j.biochi.2018.09.001. Epub 2018 Sep 5.
5
Advancements in Aptamer Discovery Technologies.适体发现技术的进展。
Acc Chem Res. 2016 Sep 20;49(9):1903-10. doi: 10.1021/acs.accounts.6b00283. Epub 2016 Aug 15.
6
Recent developments in cell-SELEX technology for aptamer selection.细胞 SELEX 技术在适配体筛选中的最新进展。
Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2323-2329. doi: 10.1016/j.bbagen.2018.07.029. Epub 2018 Jul 27.
7
The Development and Characterisation of ssDNA Aptamers via a Modified Cell-SELEX Methodology for the Detection of Human Red Blood Cells.通过改良的细胞 SELEX 方法开发和鉴定 ssDNA 适体用于检测人红细胞。
Int J Mol Sci. 2024 Feb 2;25(3):1814. doi: 10.3390/ijms25031814.
8
Screening of DNA Signaling Aptamer from Multiple Candidates Obtained from SELEX with Next-generation Sequencing.利用下一代测序技术从SELEX获得的多个候选物中筛选DNA信号适配体。
Anal Sci. 2019;35(1):113-116. doi: 10.2116/analsci.18SDN05.
9
Aptamer Technology and Its Applications in Bone Diseases.适体技术及其在骨病中的应用。
Cell Transplant. 2023 Jan-Dec;32:9636897221144949. doi: 10.1177/09636897221144949.
10
Differential binding cell-SELEX method to identify cell-specific aptamers using high-throughput sequencing.高通量测序的差异结合细胞 SELEX 方法鉴定细胞特异性适配体。
Sci Rep. 2019 May 31;9(1):8142. doi: 10.1038/s41598-019-44654-w.

引用本文的文献

1
Elucidating the molecular docking and binding dynamics of aptamers with spike proteins across SARS-CoV-2 variants of concern.阐明适体与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变异株的刺突蛋白之间的分子对接和结合动力学。
Front Microbiol. 2025 Feb 14;16:1503890. doi: 10.3389/fmicb.2025.1503890. eCollection 2025.

本文引用的文献

1
Multiplex Protein Profiling by Low-Signal-Loss Single-Cell Western Blotting with Fluorescent-Quenching Aptamers.利用荧光猝灭适体的低信号损失单细胞 Western 印迹进行多重蛋白质分析。
Anal Chem. 2023 Aug 1;95(30):11399-11409. doi: 10.1021/acs.analchem.3c01577. Epub 2023 Jul 17.
2
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development.免疫检查点 B7-H3(CD276)研究和药物开发的新前沿。
Mol Cancer. 2023 Mar 2;22(1):43. doi: 10.1186/s12943-023-01751-9.
3
Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity.
具有不同特异性的生物成像核酸适配体在人胶质母细胞瘤组织中的研究凸显肿瘤异质性
Pharmaceutics. 2022 Sep 20;14(10):1980. doi: 10.3390/pharmaceutics14101980.
4
A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer.基于流式细胞术的细胞表面蛋白结合分析,用于评估一种抗癌适体的选择性和特异性。
J Vis Exp. 2022 Sep 13(187). doi: 10.3791/64304.
5
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX.通过细胞 SELEX 技术筛选针对视网膜母细胞瘤的 DNA 适体的开发和鉴定。
Sci Rep. 2022 Sep 28;12(1):16178. doi: 10.1038/s41598-022-20660-3.
6
Competitive ELISA for a serologic test to detect dengue serotype-specific anti-NS1 IgGs using high-affinity UB-DNA aptamers.采用高亲和力 UB-DNA 适体的竞争性 ELISA 检测登革热血清型特异性抗 NS1 IgG 的血清学检测方法。
Sci Rep. 2021 Sep 9;11(1):18000. doi: 10.1038/s41598-021-97339-8.
7
B7-H3/CD276: An Emerging Cancer Immunotherapy.B7-H3/CD276:一种新兴的癌症免疫疗法。
Front Immunol. 2021 Jul 19;12:701006. doi: 10.3389/fimmu.2021.701006. eCollection 2021.
8
Aptamers as the powerhouse of dot blot assays.适配体作为点印迹分析的强大动力。
Talanta. 2021 Sep 1;232:122436. doi: 10.1016/j.talanta.2021.122436. Epub 2021 Apr 29.
9
Aptamer-Based Western Blot for Selective Protein Recognition.基于适配体的蛋白质免疫印迹法用于选择性蛋白质识别。
Front Chem. 2020 Oct 29;8:570528. doi: 10.3389/fchem.2020.570528. eCollection 2020.
10
Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers.靶向N-钙黏蛋白的DNA适配体的分离及利用双适配体高效捕获循环肿瘤细胞
Nanoscale. 2020 Nov 19;12(44):22574-22585. doi: 10.1039/d0nr06180h.